Serum Institute earlier said that its vaccine would cost Rs 400 per dose for state governments and Rs 600 per dose for private hospitals.
Bharat Biotech said that the vaccine not only had an excellent safety profile but it was formulated with adjuvants to improve immune response. Further, once opened, the vial could be kept at 2-8 degrees for 28 days, thus reducing wastage, it claimed.
The Phase-III clinical studies have shown that the vaccine has 78 per cent efficacy against Covid 19, and 100 per cent against a severe form of the disease. The company also noted that the manufacturing process was expensive due to low process yields, and that it was important to recover costs to invest in future R&D.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)